Key result
Drug-eluting stents significantly reduced the rate of major adverse cardiac events and clinical restenosis at 30-month follow-up compared to bare metal stents.
Why the study?
Do drug-eluting stents reduce major adverse cardiac events and clinical restenosis compared to bare metal stents in patients undergoing successful elective PCI?
Cohort (n=740)
Do drug-eluting stents reduce major adverse cardiac events and clinical restenosis compared to bare metal stents in patients undergoing successful elective PCI?
Drug-eluting stents independently predict lower rates of long-term MACE and clinical restenosis compared to bare metal stents after elective PCI.
Answers are grounded in this paper and cite their sources.
Supports DES consideration in elective PCI; leaves open need for randomized confirmation of long-term benefit.
Limited data exist regarding the predictors of long-term clinical outcomes following elective percutaneous coronary intervention (PCI) in the current era of stenting. The authors investigated the predictors of major adverse cardiac events (MACE) and clinical restenosis in 740 consecutive patients who underwent successful elective PCI with bare metal stents (BMSs) or drug-eluting stents (DESs). At 30-month follow-up, compared with BMS recipients, DES recipients had a significantly lower rate of MACE, which was mainly driven by a decreased repeat target vessel PCI. The rate of 30-month clinical restenosis was significantly lower in DES recipients. The authors conclude that baseline clinical, angiographic, and procedural characteristics determine long-term MACE and clinical restenosis after elective PCI, with DES being the independent predictor for both.
No takes yet. Share an insight, caveat, or question.
Cai et al. (2008) conducted a cohort in Elective percutaneous coronary intervention (n=740). Drug-eluting stents (DES) vs. Bare metal stents (BMS) was evaluated on Major adverse cardiac events (MACE) and clinical restenosis. Drug-eluting stents significantly reduced the rate of major adverse cardiac events and clinical restenosis at 30-month follow-up compared to bare metal stents.
Synapse has enriched 10 related papers. Consider them for comparative context: